The Food and Drug Administration (FDA) cleared the first blood test recently to help diagnose Alzheimer's disease.

By reprogramming the behavior of brain cells, new gene therapy could stop Alzheimer’s at the source.

A colorized computed tomography (CT) scan of the brain revealing blood vessels in the brain. A new study finds microplastics accumulate at higher levels in human ... by injury or disease, it ...

The glymphatic system flushes out waste products from the brain – now scientists have found a way to boost it in mice, which ...

Magic mushrooms” may conjure images of people in the 1960s using hallucinogenic drugs to launch journeys of self-discovery.

The U.S. Food and Drug Administration cleared the first in vitro diagnostic device that tests blood to aid in diagnosing ...

Dr. Richard G. Stefanacci explains why the FDA's recent clearance of a diagnostic blood test for Alzheimer's deserves ...

traumatic brain injury (TBI) and Alzheimer’s disease (AD). The aberrant expression of CathB drives tumor invasiveness and metastasis and exacerbates neurodegeneration and behavioral deficits in AD and ...

Cerebrospinal fluid can sometimes leak or collect in the brain without an identifiable cause, leading to symptoms that can be difficult to diagnose.

The test allows for much earlier detection of the disease, even before clear memory or behavioural symptoms appear ...

The patient was unknowingly infected with an abnormal protein that causes a rare, fatal neurological disease with no ...

Fact checked by Jennifer Klump A newly approved blood test could make it easier and less costly to detect Alzheimer's disease, allowing clinicians to diagnose and treat the condition at an earlier ...